Mitochondrial protein phosphorylation and cardiomyopathy in genetically diabetic mice: the effect of estrone treatment

Biochemical and Biophysical Research Communications
T H KuoJ Wiener

Abstract

The alpha-subunit of pyruvate dehydrogenase and succinyl-CoA synthetase are phosphorylated after incubation of cardiac mitochondria from genetically diabetic mice with [gamma-32P]ATP. There is significantly increased incorporation of 32P into pyruvate dehydrogenase from diabetic mice when compared to controls. The enhanced rate of pyruvate dehydrogenase phosphorylation correlates well with the previously reported defective oxidative metabolism and decreased activity of this enzyme from diabetic mice. The relationship between abnormal mitochondrial function and development of cardiomyopathy in the diabetic mice has been studied further by in vivo estrone treatment. The results indicate that ultrastructural alterations of myocardium are closely associated with the defective pyruvate oxidation (via phosphorylation of pyruvate dehydrogenase) and both processes can be prevented by 7-12 weeks estrone treatment.

Citations

Jul 19, 2006·Canadian Journal of Physiology and Pharmacology·Michael P CzubrytBernard Abrenica
Jan 1, 1991·Journal of Receptor Research·B H ChuaC J Krebs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Shao-Hua YangJames W Simpkins
American Journal of Physiology. Heart and Circulatory Physiology
Maryanne SkavdahlElizabeth Murphy
© 2021 Meta ULC. All rights reserved